AEs are analyzed using MLG categorizations and presenting incidence proportions as crude percentages and incidence rates per 100 patient-years considering the subjects’ exposure to study drug.For MLG Oral and gastrointestinal tract hemorrhage and MLGs Anemia or hemorrhagic Anemia, time to event analyses showing cumulative incidences based on Aalen-Johansen estimates using death as a competing risk are provided.